PCN191 Economic Evaluation of XELOX vs FOLFOX4 as Adjuvant Treatment for Patients with Stage III Colon Cancer in south Korea
Abstract
Authors
C.M. Kim S.Y. Ju S.H. Kim M. Kang J. Park W.S. Choi
C.M. Kim S.Y. Ju S.H. Kim M. Kang J. Park W.S. Choi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now